Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting 118
Thursday, October 25, 2018, 8:28 a.m. to 9:29 a.m.
Bill Casey, Chair (Liberal)

Library of Parliament
• Karin Phillips, Analyst
• Marlisa Tiedemann, Analyst
Janssen Inc. Pharmaceutical Companies of Johnson & Johnson
• Jacqueline Dobson, Government Affairs and Policy Manager, Government Affairs and Market Access
• Stacey Silverberg, Stakeholder Engagement Manager, Government Affairs and Market Access
Children's Hospital of Eastern Ontario (CHEO)
• Alex Mackenzie, Clinician Scientist
As individuals
• Michael Brudno, Professor and Scientific Director, Centre for Computational Medicine, Hospital for Sick Children
• Joel Lexchin, Professor Emeritus, School of Health Policy and Management, York University
• Ian Stedman, Osgoode Hall Law School, York University
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Wednesday, April 18, 2018, the Committee resumed its study on barriers to access to treatment and drugs for Canadians affected by rare diseases and disorders.

Michael Brudno, Ian Stedman, Alex Mackenzie, Joel Lexchin, and Stacey Silverberg made statements and, with Jacqueline Dobson, answered questions.

At 9:29 a.m., the Committee adjourned to the call of the Chair.

Marie-Hélène Sauvé
Clerk of the Committee